Kos Bolsters Internal Sales Force To 1,000 Ahead Of New Launches

The company will not renew a co-promotion agreement with Takeda for Niaspan and Advicor.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet